AMENDMENT NO. 4 TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • October 30th, 2019 • Incyte Corp • Services-commercial physical & biological research
Contract Type FiledOctober 30th, 2019 Company IndustryTHIS AMENDMENT NO. 4 TO COLLABORATION AND LICENSE AGREEMENT (this “Amendment No. 4”) is entered into as of the 5th day of April, 2016 (the “Effective Date”), by and between Incyte Corporation, a Delaware corporation having an office at 1801 Augustine Cut-Off, Wilmington, Delaware (“Incyte”), and Novartis International Pharmaceutical Ltd., a limited company organized under the laws of Bermuda having an office at 131 Front Street, Hamilton, Bermuda HM 12 (“Novartis”).
AMENDMENT NO. 4 TOCollaboration and License Agreement • August 9th, 2016 • Incyte Corp • Services-commercial physical & biological research
Contract Type FiledAugust 9th, 2016 Company IndustryTHIS AMENDMENT NO. 4 TO COLLABORATION AND LICENSE AGREEMENT (this “Amendment No. 4”) is entered into as of the 5th day of April, 2016 (the “Effective Date”), by and between Incyte Corporation, a Delaware corporation having an office at 1801 Augustine Cut-Off, Wilmington, Delaware (“Incyte”), and Novartis International Pharmaceutical Ltd., a limited company organized under the laws of Bermuda having an office at 131 Front Street, Hamilton, Bermuda HM 12 (“Novartis”).